0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Liquid Tumor Biopsy Market Research Report 2023
Published Date: February 2023
|
Report Code: QYRE-Auto-38T9581
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Liquid Tumor Biopsy Market Insights Forecast to 2028
BUY CHAPTERS

Global Liquid Tumor Biopsy Market Research Report 2023

Code: QYRE-Auto-38T9581
Report
February 2023
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Liquid Tumor Biopsy Market

Liquid biopsy is an emerging and non-invasive method of genetic testing, which is applicable to a variety of symptoms and a wide range of applications.
The global Liquid Tumor Biopsy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Liquid Tumor Biopsy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Liquid Tumor Biopsy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Liquid Tumor Biopsy in Clinical Laboratories is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Liquid Tumor Biopsy include Abbott Laboratories, Bio-Rad Laboratories, F. Hoffmann-La Roche, Illumina, QIAGEN N.V., Thermo Fisher Scientific, Amoy Diagnostics, HaploX and Whole Genome Sequencing, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Liquid Tumor Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Tumor Biopsy.
The Liquid Tumor Biopsy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Liquid Tumor Biopsy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liquid Tumor Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Key Segmentations

By Company

  • Abbott Laboratories
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • Illumina
  • QIAGEN N.V.
  • Thermo Fisher Scientific
  • Amoy Diagnostics
  • HaploX
  • Whole Genome Sequencing
  • Burning Rock Biotech

Segment by Type

  • ctDNA
  • CTC

Segment by Application

  • Clinical Laboratories
  • Hospital

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Liquid Tumor Biopsy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

Scope of Global Liquid Tumor Biopsy Market Report

Report MetricDetails
Report NameGlobal Liquid Tumor Biopsy Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liquid Tumor Biopsy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 ctDNA
1.2.3 CTC
1.3 Market by Application
1.3.1 Global Liquid Tumor Biopsy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clinical Laboratories
1.3.3 Hospital
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liquid Tumor Biopsy Market Perspective (2018-2029)
2.2 Liquid Tumor Biopsy Growth Trends by Region
2.2.1 Global Liquid Tumor Biopsy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Liquid Tumor Biopsy Historic Market Size by Region (2018-2023)
2.2.3 Liquid Tumor Biopsy Forecasted Market Size by Region (2024-2029)
2.3 Liquid Tumor Biopsy Market Dynamics
2.3.1 Liquid Tumor Biopsy Industry Trends
2.3.2 Liquid Tumor Biopsy Market Drivers
2.3.3 Liquid Tumor Biopsy Market Challenges
2.3.4 Liquid Tumor Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liquid Tumor Biopsy Players by Revenue
3.1.1 Global Top Liquid Tumor Biopsy Players by Revenue (2018-2023)
3.1.2 Global Liquid Tumor Biopsy Revenue Market Share by Players (2018-2023)
3.2 Global Liquid Tumor Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liquid Tumor Biopsy Revenue
3.4 Global Liquid Tumor Biopsy Market Concentration Ratio
3.4.1 Global Liquid Tumor Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liquid Tumor Biopsy Revenue in 2022
3.5 Liquid Tumor Biopsy Key Players Head office and Area Served
3.6 Key Players Liquid Tumor Biopsy Product Solution and Service
3.7 Date of Enter into Liquid Tumor Biopsy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Liquid Tumor Biopsy Breakdown Data by Type
4.1 Global Liquid Tumor Biopsy Historic Market Size by Type (2018-2023)
4.2 Global Liquid Tumor Biopsy Forecasted Market Size by Type (2024-2029)
5 Liquid Tumor Biopsy Breakdown Data by Application
5.1 Global Liquid Tumor Biopsy Historic Market Size by Application (2018-2023)
5.2 Global Liquid Tumor Biopsy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Liquid Tumor Biopsy Market Size (2018-2029)
6.2 North America Liquid Tumor Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Liquid Tumor Biopsy Market Size by Country (2018-2023)
6.4 North America Liquid Tumor Biopsy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liquid Tumor Biopsy Market Size (2018-2029)
7.2 Europe Liquid Tumor Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Liquid Tumor Biopsy Market Size by Country (2018-2023)
7.4 Europe Liquid Tumor Biopsy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liquid Tumor Biopsy Market Size (2018-2029)
8.2 Asia-Pacific Liquid Tumor Biopsy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Liquid Tumor Biopsy Market Size by Region (2018-2023)
8.4 Asia-Pacific Liquid Tumor Biopsy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liquid Tumor Biopsy Market Size (2018-2029)
9.2 Latin America Liquid Tumor Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Liquid Tumor Biopsy Market Size by Country (2018-2023)
9.4 Latin America Liquid Tumor Biopsy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liquid Tumor Biopsy Market Size (2018-2029)
10.2 Middle East & Africa Liquid Tumor Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Liquid Tumor Biopsy Market Size by Country (2018-2023)
10.4 Middle East & Africa Liquid Tumor Biopsy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Liquid Tumor Biopsy Introduction
11.1.4 Abbott Laboratories Revenue in Liquid Tumor Biopsy Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Liquid Tumor Biopsy Introduction
11.2.4 Bio-Rad Laboratories Revenue in Liquid Tumor Biopsy Business (2018-2023)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Detail
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Liquid Tumor Biopsy Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Liquid Tumor Biopsy Business (2018-2023)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Illumina
11.4.1 Illumina Company Detail
11.4.2 Illumina Business Overview
11.4.3 Illumina Liquid Tumor Biopsy Introduction
11.4.4 Illumina Revenue in Liquid Tumor Biopsy Business (2018-2023)
11.4.5 Illumina Recent Development
11.5 QIAGEN N.V.
11.5.1 QIAGEN N.V. Company Detail
11.5.2 QIAGEN N.V. Business Overview
11.5.3 QIAGEN N.V. Liquid Tumor Biopsy Introduction
11.5.4 QIAGEN N.V. Revenue in Liquid Tumor Biopsy Business (2018-2023)
11.5.5 QIAGEN N.V. Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Detail
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Liquid Tumor Biopsy Introduction
11.6.4 Thermo Fisher Scientific Revenue in Liquid Tumor Biopsy Business (2018-2023)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Amoy Diagnostics
11.7.1 Amoy Diagnostics Company Detail
11.7.2 Amoy Diagnostics Business Overview
11.7.3 Amoy Diagnostics Liquid Tumor Biopsy Introduction
11.7.4 Amoy Diagnostics Revenue in Liquid Tumor Biopsy Business (2018-2023)
11.7.5 Amoy Diagnostics Recent Development
11.8 HaploX
11.8.1 HaploX Company Detail
11.8.2 HaploX Business Overview
11.8.3 HaploX Liquid Tumor Biopsy Introduction
11.8.4 HaploX Revenue in Liquid Tumor Biopsy Business (2018-2023)
11.8.5 HaploX Recent Development
11.9 Whole Genome Sequencing
11.9.1 Whole Genome Sequencing Company Detail
11.9.2 Whole Genome Sequencing Business Overview
11.9.3 Whole Genome Sequencing Liquid Tumor Biopsy Introduction
11.9.4 Whole Genome Sequencing Revenue in Liquid Tumor Biopsy Business (2018-2023)
11.9.5 Whole Genome Sequencing Recent Development
11.10 Burning Rock Biotech
11.10.1 Burning Rock Biotech Company Detail
11.10.2 Burning Rock Biotech Business Overview
11.10.3 Burning Rock Biotech Liquid Tumor Biopsy Introduction
11.10.4 Burning Rock Biotech Revenue in Liquid Tumor Biopsy Business (2018-2023)
11.10.5 Burning Rock Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Liquid Tumor Biopsy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of ctDNA
    Table 3. Key Players of CTC
    Table 4. Global Liquid Tumor Biopsy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 5. Global Liquid Tumor Biopsy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Liquid Tumor Biopsy Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Liquid Tumor Biopsy Market Share by Region (2018-2023)
    Table 8. Global Liquid Tumor Biopsy Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Liquid Tumor Biopsy Market Share by Region (2024-2029)
    Table 10. Liquid Tumor Biopsy Market Trends
    Table 11. Liquid Tumor Biopsy Market Drivers
    Table 12. Liquid Tumor Biopsy Market Challenges
    Table 13. Liquid Tumor Biopsy Market Restraints
    Table 14. Global Liquid Tumor Biopsy Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Liquid Tumor Biopsy Market Share by Players (2018-2023)
    Table 16. Global Top Liquid Tumor Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Tumor Biopsy as of 2022)
    Table 17. Ranking of Global Top Liquid Tumor Biopsy Companies by Revenue (US$ Million) in 2022
    Table 18. Global 5 Largest Players Market Share by Liquid Tumor Biopsy Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Liquid Tumor Biopsy Product Solution and Service
    Table 21. Date of Enter into Liquid Tumor Biopsy Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Liquid Tumor Biopsy Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Liquid Tumor Biopsy Revenue Market Share by Type (2018-2023)
    Table 25. Global Liquid Tumor Biopsy Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Liquid Tumor Biopsy Revenue Market Share by Type (2024-2029)
    Table 27. Global Liquid Tumor Biopsy Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Liquid Tumor Biopsy Revenue Market Share by Application (2018-2023)
    Table 29. Global Liquid Tumor Biopsy Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Liquid Tumor Biopsy Revenue Market Share by Application (2024-2029)
    Table 31. North America Liquid Tumor Biopsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 32. North America Liquid Tumor Biopsy Market Size by Country (2018-2023) & (US$ Million)
    Table 33. North America Liquid Tumor Biopsy Market Size by Country (2024-2029) & (US$ Million)
    Table 34. Europe Liquid Tumor Biopsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. Europe Liquid Tumor Biopsy Market Size by Country (2018-2023) & (US$ Million)
    Table 36. Europe Liquid Tumor Biopsy Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Asia-Pacific Liquid Tumor Biopsy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Asia-Pacific Liquid Tumor Biopsy Market Size by Region (2018-2023) & (US$ Million)
    Table 39. Asia-Pacific Liquid Tumor Biopsy Market Size by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Liquid Tumor Biopsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Latin America Liquid Tumor Biopsy Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Latin America Liquid Tumor Biopsy Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Middle East & Africa Liquid Tumor Biopsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Middle East & Africa Liquid Tumor Biopsy Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Middle East & Africa Liquid Tumor Biopsy Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Abbott Laboratories Company Detail
    Table 47. Abbott Laboratories Business Overview
    Table 48. Abbott Laboratories Liquid Tumor Biopsy Product
    Table 49. Abbott Laboratories Revenue in Liquid Tumor Biopsy Business (2018-2023) & (US$ Million)
    Table 50. Abbott Laboratories Recent Development
    Table 51. Bio-Rad Laboratories Company Detail
    Table 52. Bio-Rad Laboratories Business Overview
    Table 53. Bio-Rad Laboratories Liquid Tumor Biopsy Product
    Table 54. Bio-Rad Laboratories Revenue in Liquid Tumor Biopsy Business (2018-2023) & (US$ Million)
    Table 55. Bio-Rad Laboratories Recent Development
    Table 56. F. Hoffmann-La Roche Company Detail
    Table 57. F. Hoffmann-La Roche Business Overview
    Table 58. F. Hoffmann-La Roche Liquid Tumor Biopsy Product
    Table 59. F. Hoffmann-La Roche Revenue in Liquid Tumor Biopsy Business (2018-2023) & (US$ Million)
    Table 60. F. Hoffmann-La Roche Recent Development
    Table 61. Illumina Company Detail
    Table 62. Illumina Business Overview
    Table 63. Illumina Liquid Tumor Biopsy Product
    Table 64. Illumina Revenue in Liquid Tumor Biopsy Business (2018-2023) & (US$ Million)
    Table 65. Illumina Recent Development
    Table 66. QIAGEN N.V. Company Detail
    Table 67. QIAGEN N.V. Business Overview
    Table 68. QIAGEN N.V. Liquid Tumor Biopsy Product
    Table 69. QIAGEN N.V. Revenue in Liquid Tumor Biopsy Business (2018-2023) & (US$ Million)
    Table 70. QIAGEN N.V. Recent Development
    Table 71. Thermo Fisher Scientific Company Detail
    Table 72. Thermo Fisher Scientific Business Overview
    Table 73. Thermo Fisher Scientific Liquid Tumor Biopsy Product
    Table 74. Thermo Fisher Scientific Revenue in Liquid Tumor Biopsy Business (2018-2023) & (US$ Million)
    Table 75. Thermo Fisher Scientific Recent Development
    Table 76. Amoy Diagnostics Company Detail
    Table 77. Amoy Diagnostics Business Overview
    Table 78. Amoy Diagnostics Liquid Tumor Biopsy Product
    Table 79. Amoy Diagnostics Revenue in Liquid Tumor Biopsy Business (2018-2023) & (US$ Million)
    Table 80. Amoy Diagnostics Recent Development
    Table 81. HaploX Company Detail
    Table 82. HaploX Business Overview
    Table 83. HaploX Liquid Tumor Biopsy Product
    Table 84. HaploX Revenue in Liquid Tumor Biopsy Business (2018-2023) & (US$ Million)
    Table 85. HaploX Recent Development
    Table 86. Whole Genome Sequencing Company Detail
    Table 87. Whole Genome Sequencing Business Overview
    Table 88. Whole Genome Sequencing Liquid Tumor Biopsy Product
    Table 89. Whole Genome Sequencing Revenue in Liquid Tumor Biopsy Business (2018-2023) & (US$ Million)
    Table 90. Whole Genome Sequencing Recent Development
    Table 91. Burning Rock Biotech Company Detail
    Table 92. Burning Rock Biotech Business Overview
    Table 93. Burning Rock Biotech Liquid Tumor Biopsy Product
    Table 94. Burning Rock Biotech Revenue in Liquid Tumor Biopsy Business (2018-2023) & (US$ Million)
    Table 95. Burning Rock Biotech Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Liquid Tumor Biopsy Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Liquid Tumor Biopsy Market Share by Type: 2022 VS 2029
    Figure 3. ctDNA Features
    Figure 4. CTC Features
    Figure 5. Global Liquid Tumor Biopsy Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 6. Global Liquid Tumor Biopsy Market Share by Application: 2022 VS 2029
    Figure 7. Clinical Laboratories Case Studies
    Figure 8. Hospital Case Studies
    Figure 9. Liquid Tumor Biopsy Report Years Considered
    Figure 10. Global Liquid Tumor Biopsy Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 11. Global Liquid Tumor Biopsy Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 12. Global Liquid Tumor Biopsy Market Share by Region: 2022 VS 2029
    Figure 13. Global Liquid Tumor Biopsy Market Share by Players in 2022
    Figure 14. Global Top Liquid Tumor Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Tumor Biopsy as of 2022)
    Figure 15. The Top 10 and 5 Players Market Share by Liquid Tumor Biopsy Revenue in 2022
    Figure 16. North America Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 17. North America Liquid Tumor Biopsy Market Share by Country (2018-2029)
    Figure 18. United States Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. Canada Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. Europe Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Europe Liquid Tumor Biopsy Market Share by Country (2018-2029)
    Figure 22. Germany Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. France Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. U.K. Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Italy Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Russia Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Nordic Countries Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Asia-Pacific Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Asia-Pacific Liquid Tumor Biopsy Market Share by Region (2018-2029)
    Figure 30. China Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Japan Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. South Korea Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Southeast Asia Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. India Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Australia Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Latin America Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Latin America Liquid Tumor Biopsy Market Share by Country (2018-2029)
    Figure 38. Mexico Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Brazil Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Middle East & Africa Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Middle East & Africa Liquid Tumor Biopsy Market Share by Country (2018-2029)
    Figure 42. Turkey Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Saudi Arabia Liquid Tumor Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Abbott Laboratories Revenue Growth Rate in Liquid Tumor Biopsy Business (2018-2023)
    Figure 45. Bio-Rad Laboratories Revenue Growth Rate in Liquid Tumor Biopsy Business (2018-2023)
    Figure 46. F. Hoffmann-La Roche Revenue Growth Rate in Liquid Tumor Biopsy Business (2018-2023)
    Figure 47. Illumina Revenue Growth Rate in Liquid Tumor Biopsy Business (2018-2023)
    Figure 48. QIAGEN N.V. Revenue Growth Rate in Liquid Tumor Biopsy Business (2018-2023)
    Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Liquid Tumor Biopsy Business (2018-2023)
    Figure 50. Amoy Diagnostics Revenue Growth Rate in Liquid Tumor Biopsy Business (2018-2023)
    Figure 51. HaploX Revenue Growth Rate in Liquid Tumor Biopsy Business (2018-2023)
    Figure 52. Whole Genome Sequencing Revenue Growth Rate in Liquid Tumor Biopsy Business (2018-2023)
    Figure 53. Burning Rock Biotech Revenue Growth Rate in Liquid Tumor Biopsy Business (2018-2023)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS